Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked a purchase and development deal with Interventional Spine to pick up its expandable cages designed for minimally invasive spinal fusion surgeries.
The newly acquired implants are designed for optimal tactile feedback and feature a continuously adjustable design to allow for height to be customized to the patient’s anatomy, the company said.
The expandable cages are designed to maximize bone graft contact and containment to promote bone growth and fusion, the companies said.
“DePuy Synthes and Interventional Spine have a common goal—advancing spinal care for patients with debilitating degenerative disc disease and expanding access to this important technology globally. Through this collaboration with Interventional Spine, we will broaden our product offering in a strategic platform and reach more customers and patients around the world,” group chair Ciro Römer said in prepared remarks.
DePuy Synthes said it is also picking up Interventional Spine’s facet screw system designed for percutaneous spine surgery. The companies did not release financial terms of the purchase and development deal.
Last November, DePuy Synthes said it launched a new program for outpatient joint replacement procedures, DePuy Synthes Advantage.
The Advantage program covers hip, knee and shoulder replacements by providing education, training and professional and patient support services, Warsaw, Ind.-based DePuy Synthes said. More than 500 healthcare professionals have been trained in the outpatient program since its pilot, the company said.